Does Rallies show 13F holders for AUPH?

Yes. Rallies tracks hedge fund and 13F ownership data for AUPH, including fund names, share counts, latest tracked quarter, and position changes when available.

Is AUPH research on Rallies investment advice?

No. Rallies provides research, data, and educational context for AUPH. It does not provide personalized investment advice.

AUPH (Aurinia Pharmaceuticals Inc) Stock Analysis - Hedge Fund Holdings

Aurinia Pharmaceuticals Inc (AUPH) is a publicly traded Healthcare sector company. As of May 19, 2026, AUPH trades at $15.65 with a market cap of $1.97B and a P/E ratio of 6.86. AUPH moved +0.51% today. Year to date, AUPH is +1.63%; over the trailing twelve months it is +90.48%. Its 52-week range spans $6.55 to $16.88. Analyst consensus is buy with an average price target of $16.00. Rallies surfaces AUPH's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns AUPH stock?

Hedge funds tracked by Rallies that own AUPH include Exoduspoint Capital. The latest tracked quarter is Sep 30, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Aurinia Pharmaceuticals Inc.

AUPH Key Metrics

Key financial metrics for AUPH
Metric	Value
Price	$15.65
Market Cap	$1.97B
P/E Ratio	6.86
EPS	$2.26
Dividend Yield	0.00%
52-Week High	$16.88
52-Week Low	$6.55
Volume	323.13K
Avg Volume	0
Revenue (TTM)	$298.30M
Net Income	$298.21M
Gross Margin	89.74%

Top Hedge Funds Holding AUPH

Exoduspoint Capital holds 72.46K shares of AUPH, changed -44.34% as of Sep 30, 2025.

Latest AUPH News

Aurinia Pharmaceuticals Completes $41.2M Tender Offer Acquiring 80.24% of Kezar Shares — May 19, 2026
Aurinia Posts $24.8M Q1 Revenue, Narrows Loss to $0.20/Share with $342M Cash — May 7, 2026
Aurinia Pharmaceuticals Q4 EPS at $0.26 Doubles From Year Ago, Tops Estimates — Feb 26, 2026

Recent AUPH Insider Trades

TANG KEVIN bought 184.21K (~$2.62M) on Mar 3, 2026.
TANG KEVIN bought 83.56K (~$1.20M) on Mar 2, 2026.
TANG KEVIN bought 115.79K (~$1.65M) on Mar 2, 2026.

AUPH Analyst Consensus

4 analysts cover AUPH: 0 strong buy, 2 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $16.00.

Common questions about AUPH

Who owns AUPH stock?: Hedge funds tracked by Rallies that own AUPH include Exoduspoint Capital. The latest tracked quarter is Sep 30, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Aurinia Pharmaceuticals Inc.
Does Rallies show 13F holders for AUPH?: Yes. Rallies tracks hedge fund and 13F ownership data for AUPH, including fund names, share counts, latest tracked quarter, and position changes when available.
Is AUPH research on Rallies investment advice?: No. Rallies provides research, data, and educational context for AUPH. It does not provide personalized investment advice.